— Know what they know.
Not Investment Advice
Also trades as: 0R0H.L (LSE) · $vol 3M · TN8.DE (XETRA) · $vol 0M · TMO.TO (TSX) · $vol 0M · TMO.NE (NEO) · $vol 0M

TMO NYSE

Thermo Fisher Scientific Inc.
1W: +0.8% 1M: +1.4% 3M: +18.8% YTD: +15.6% 1Y: +19.8% 3Y: +46.8% 5Y: +17.8%
$693.13
+8.24 (+1.20%)
After Hours: $697.09 (+3.96, +0.57%)
Weekly Expected Move ±4.1%
$619 $647 $674 $701 $729
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 70 · $253.2B mcap · 369M float · 0.594% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 79% of companies Debt: 14.0% of company value Bonds: $454.1M held by 353 funds, 52 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $7.50 (down 99%), Thermo Fisher Scientific Inc. would be worth roughly what it owes.
Total debt $41.37B against a stock market value of $253.24B.
Distance to default 9.42 (Merton model): prices to 2026-10-26, balance sheet 2026-09-26, debt counted $21.82B (short-term plus half of long-term), stock volatility 29.2%; Altman Z'' 2.15. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$110.3B +13.4% ▲
5Y CAGR: +9.8%
Total Liabilities
$56.8B +19.2% ▲
5Y CAGR: +10.5%
Shareholders Equity
$53.4B +7.7% ▲
5Y CAGR: +9.1%
Cash & Investments
$10.1B +81.5% ▲
5Y CAGR: -0.4%
Total Debt
$40.9B +24.7% ▲
5Y CAGR: +12.6%
Net Debt
$31.0B +7.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$4.5B$8.5B$8.1B$4.0B$9.9B
Short-Term Investments$0$0$0$1.6B$253M
Cash & ST Investments$4.5B$8.5B$8.1B$5.6B$10.1B
Net Receivables$8.9B$9.4B$9.7B$9.6B$10.6B
Inventory$5.1B$5.6B$5.1B$5.0B$5.4B
Other Current Assets$1.6B$1.6B$1.8B$2.0B$2.6B
Total Current Assets$20.1B$25.2B$24.6B$22.1B$28.7B
Property, Plant & Equip.$9.9B$10.9B$11.0B$10.8B$12.0B
Goodwill & Intangibles$62.1B$58.7B$60.7B$61.4B$65.2B
Long-Term Investments$73M$155M$59M$560M$541M
Other Non-Current Assets$3.0B$2.2B$2.4B$2.4B$3.9B
Total Non-Current Assets$75.0B$71.9B$74.1B$75.2B$81.6B
Total Assets$95.1B$97.2B$98.7B$97.3B$110.3B
— Liabilities —
Accounts Payable$2.9B$3.4B$2.9B$3.1B$3.6B
Short-Term Debt$2.8B$5.9B$3.9B$2.5B$3.8B
Deferred Revenue$2.7B$2.6B$2.7B$2.9B$2.7B
Other Current Liabilities$2.7B$3.1B$3.0B$2.9B$3.1B
Total Current Liabilities$13.4B$17.0B$14.0B$13.3B$15.2B
Long-Term Debt$32.1B$28.9B$31.3B$29.1B$35.9B
Other Non-Current Liab.$2.1B$1.7B$1.9B$1.6B$1.9B
Total Non-Current Liabilities$40.7B$36.0B$37.9B$34.3B$41.6B
Total Liabilities$54.1B$53.0B$51.9B$47.6B$56.8B
— Equity —
Common Stock$439M$441M$442M$444M$445M
Retained Earnings$35.4B$41.9B$47.4B$53.1B$59.2B
Accumulated OCI-$2.3B-$3.1B-$3.2B-$2.7B-$2.4B
Total Stockholders Equity$40.8B$44.0B$46.7B$49.6B$53.4B
Total Liabilities & Equity$95.1B$97.2B$98.7B$97.3B$110.3B
— Key Metrics —
Total Debt$36.3B$36.1B$36.4B$32.8B$40.9B
Net Debt$31.8B$27.5B$28.3B$28.8B$31.0B
Total Investments$73M$155M$59M$2.1B$794M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms